Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetic nephropathy in the elderly.

J F Blicklé1, J Doucet, T Krummel

  • 1Service de médecine interne, diabète et maladies métaboliques, Hôpitaux Universitaires de Strasbourg, Strasbourg, France. jean-frederic.blickle@chru-strasbourg.fr

Diabetes & Metabolism
|August 19, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Diabetes and frailty in the elderly. A prospective study of an outpatient population supported by general practitioners].

Revue medicale de Liege·2021
Same author

[Type 2 diabetes and the elderly : a real problem].

Revue medicale de Liege·2021
Same author

Evolution in geriatric syndromes and association with survival over 5 years in the GERODIAB cohort of older French diabetic patients.

European geriatric medicine·2020
Same author

Crushing drugs in geriatric units: are cleaning methods and devices appropriate?

European journal of clinical pharmacology·2018
Same author

Haemoglobin A1c and 5-year all-cause mortality in French type 2 diabetic patients aged 70 years and older: The GERODIAB observational cohort.

Diabetes & metabolism·2018
Same author

[Cardiovascular protection of diabetic patient with chronic renal disease and particular case of end-stage renal disease in elderly patients].

Nephrologie & therapeutique·2018
Same journal

Glucagon-like peptide-1 receptor agonists and risk of pancreaticobiliary cancers in patients with type 2 diabetes: a nationwide cohort study.

Diabetes & metabolism·2026
Same journal

Decreased risk of new-onset osteoporosis in patients with Type 2 diabetes on SGLT-2 inhibitors.

Diabetes & metabolism·2026
Same journal

Two faces of autoimmune hyperinsulinemia: contrasting type B insulin resistance syndrome and exogenous insulin antibody syndrome.

Diabetes & metabolism·2026
Same journal

CGM-based metrics and mortality in older adults living with type 2 diabetes on insulin therapy: a secondary analysis of the HYPOAGE study.

Diabetes & metabolism·2026
Same journal

Persistent burden and management gaps of hypoglycemia in pediatric type 1 diabetes: insights from the Epi-GLUREDIA Study.

Diabetes & metabolism·2026
Same journal

Blood oxygen saturation and its associations with autonomic and peripheral neuropathy in diabetes.

Diabetes & metabolism·2026
See all related articles

Diabetic nephropathy (DN) in older adults is driven by high blood sugar, hypertension, and aging. Effective management involves strict blood pressure and glucose control to prevent kidney failure.

Area of Science:

  • Nephrology
  • Endocrinology
  • Geriatrics

Background:

  • Renal impairment is common in elderly patients with type 2 diabetes, stemming from hyperglycemia, hypertension, and aging.
  • Diabetic nephropathy (DN) significantly increases cardiovascular mortality and can lead to end-stage renal failure (ESRF).
  • Assessing the diabetic origin of nephropathy in elderly patients is challenging without renal biopsy.

Purpose of the Study:

  • To summarize the challenges and management strategies for diabetic nephropathy in aged patients.
  • To highlight the importance of prevention and treatment adjustments in elderly diabetics with declining renal function.

Main Methods:

  • Review of existing literature on diabetic nephropathy in the elderly.
  • Analysis of contributing factors: hyperglycemia, hypertension, aging.

Related Experiment Videos

  • Discussion of diagnostic challenges and management principles.

    • Main Results:

    • Diabetic nephropathy pathogenesis is multifactorial, involving hyperglycemia, hypertension, and aging.
    • Prevention relies on tight glycemic and blood pressure control.
    • Renal lesion progression can be slowed by blood pressure management, including renin-angiotensin system blockade.
    • Avoiding nephrotoxic agents like NSAIDs and iodinated contrast media is crucial.
    • Antidiabetic treatment requires adaptation, often switching to insulin at GFR < 30 ml/min/1.73 m².

    Conclusions:

    • Strict blood pressure and glycemic control are paramount for preventing and managing diabetic nephropathy in the elderly.
    • Careful medication management, avoiding nephrotoxic substances, and adapting antidiabetic therapy are essential for preserving renal function.
    • Early intervention and tailored treatment strategies can mitigate the progression of diabetic nephropathy and its complications in aged populations.